Stockscreener 앱 받기
189.52
0.80%
-1.72
전일 마감가:
$191.24
열려 있는:
$188.2
하루 거래량:
207.38K
Relative Volume:
0.92
시가총액:
$3.71B
수익:
$152.42M
순이익/손실:
$45.24M
주가수익비율:
75.51
EPS:
2.51
순현금흐름:
$6.97M
1주 성능:
+0.45%
1개월 성능:
+4.82%
6개월 성능:
+73.43%
1년 성능:
+72.12%
1일 변동 폭
$186.28
$191.46
1주일 범위
$182.87
$193.02
52주 변동 폭
$93.58
$194.44
리간드 파마 Stock (LGND) Company Profile
명칭
Ligand Pharmaceuticals Inc
전화
858-550-7500
주소
3911 SORRENTO VALLEY BLVD, SAN DIEGO, CA
LGND을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LGND
Ligand Pharmaceuticals Inc
|
189.48 | 3.73B | 152.42M | 45.24M | 6.97M | 2.51 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.71 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.74 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.50 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
830.64 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.63 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
리간드 파마 Stock (LGND) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-10 | 개시 | Stifel | Buy |
| 2024-10-03 | 개시 | Oppenheimer | Outperform |
| 2024-07-30 | 개시 | RBC Capital Mkts | Outperform |
| 2021-04-14 | 재개 | Stephens | Overweight |
| 2021-02-04 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-06 | 개시 | Barclays | Overweight |
| 2020-03-24 | 다운그레이드 | Argus | Buy → Hold |
| 2020-03-10 | 개시 | Guggenheim | Neutral |
| 2020-02-06 | 개시 | The Benchmark Company | Buy |
| 2019-09-19 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2019-06-11 | 개시 | Barclays | Equal Weight |
| 2019-05-03 | 재확인 | H.C. Wainwright | Buy |
| 2019-03-06 | 재확인 | H.C. Wainwright | Buy |
| 2018-10-29 | 업그레이드 | ROTH Capital | Neutral → Buy |
| 2018-10-02 | 재확인 | H.C. Wainwright | Buy |
| 2018-09-11 | 재확인 | Argus | Buy |
| 2018-08-17 | 개시 | Goldman | Neutral |
| 2018-08-08 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2018-06-21 | 개시 | Argus | Buy |
| 2017-12-27 | 재확인 | H.C. Wainwright | Buy |
| 2017-09-05 | 재개 | H.C. Wainwright | Buy |
| 2016-10-05 | 재확인 | H.C. Wainwright | Buy |
| 2016-08-05 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2016-03-11 | 개시 | Sidoti | Buy |
| 2016-03-03 | 개시 | H.C. Wainwright | Buy |
모두보기
리간드 파마 주식(LGND)의 최신 뉴스
Ligand Pharmaceuticals (NASDAQ:LGND) Price Target Raised to $250.00 at Oppenheimer - MarketBeat
Will breakout in Ligand Pharmaceuticals Incorporated lead to full recoveryWeekly Risk Summary & Precise Swing Trade Alerts - newser.com
How Ligand Pharmaceuticals Incorporated (LGDN) stock compares with market leadersJuly 2025 Price Swings & AI Based Buy and Sell Signals - newser.com
Is Ligand Pharmaceuticals Incorporated reversing from oversold territoryQuarterly Portfolio Report & Advanced Swing Trade Entry Plans - newser.com
Intraday pattern recognizer results for Ligand Pharmaceuticals Incorporated2025 Top Gainers & Daily Oversold Bounce Ideas - newser.com
How supply chain issues affect Ligand Pharmaceuticals Incorporated stockBear Alert & AI Powered Buy/Sell Recommendations - newser.com
Will Ligand Pharmaceuticals Incorporated (LGDN) stock announce a stock splitMarket Sentiment Summary & Safe Entry Zone Tips - newser.com
Oppenheimer Raises Price Target for Ligand Pharmaceuticals (LGND) to $250 | LGND Stock News - GuruFocus
How to use Fibonacci retracement on Ligand Pharmaceuticals Incorporated2025 Market WrapUp & Precise Buy Zone Identification - newser.com
How Investors Are Reacting To Ligand Pharmaceuticals (LGND) Management's Engagement Surge and Analyst Optimism - Yahoo Finance
Oppenheimer Maintains Ligand Pharmaceuticals IncorporatedEquity Right (LGNDZ) Outperform Recommendation - Nasdaq
Oppenheimer Raises Price Target on Ligand Pharmaceuticals to $250 From $190, Keeps Outperform Rating - MarketScreener
Will Ligand Pharmaceuticals Incorporated (LGDN) stock hit analyst forecastsTrade Exit Summary & Detailed Earnings Play Alerts - newser.com
Can Ligand Pharmaceuticals Incorporated stock sustain market leadership2025 Support & Resistance & Daily Profit Focused Stock Screening - newser.com
Is Ligand Pharmaceuticals Incorporated (LGDN) stock attractive post correctionJuly 2025 Opening Moves & Low Risk Investment Opportunities - newser.com
Short interest data insights for Ligand Pharmaceuticals Incorporated2025 Technical Patterns & Long-Term Growth Portfolio Plans - newser.com
What catalysts could drive Ligand Pharmaceuticals Incorporated stock higher2025 Top Decliners & Weekly High Potential Stock Alerts - newser.com
What institutional flow reveals about Ligand Pharmaceuticals IncorporatedWeekly Profit Recap & Free Long-Term Investment Growth Plans - newser.com
Analyzing drawdowns of Ligand Pharmaceuticals Incorporated with statistical toolsPortfolio Growth Summary & Accurate Buy Signal Notifications - newser.com
What moving averages say about Ligand Pharmaceuticals Incorporated2025 Trading Recap & Technical Entry and Exit Alerts - newser.com
Published on: 2025-11-02 23:44:20 - newser.com
Does Ligand Pharmaceuticals Incorporated show high probability of reboundWeekly Stock Analysis & Daily Growth Stock Investment Tips - newser.com
Technical signs of recovery in Ligand Pharmaceuticals Incorporated2025 Trade Ideas & Fast Gain Stock Tips - newser.com
Is Ligand Pharmaceuticals Incorporated forming a reversal patternJuly 2025 Closing Moves & AI Forecasted Stock Moves - newser.com
리간드 파마 (LGND) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.29%
0.56%
자본화:
|
볼륨(24시간):